FDA Panels Nix Approval of Abuse-Deterrent Oxycodone for Pain FDA Panels Nix Approval of Abuse-Deterrent Oxycodone for Pain

Two FDA advisory committees voted 14-3 against approval recommendation for Remoxy ER, voicing concerns over the product ' s claims of abuse deterrence via various routes.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news